Covishield Side Effects: The talk about rare side effects of Covishield vaccine was not yet over when another scary news is coming regarding it. A new dangerous blood clotting disorder has been found in AstraZeneca’s Covishield. This has been revealed in a research. Australia’s Flinders University and some other international researchers have claimed this in their latest research.
Let us tell you that the risk of immune thrombocytopenia and thrombosis was recently found in the Covid-19 vaccine of the British-Swedish pharmaceutical company AstraZeneca, made with the help of Oxford University. In this serious disease, blood clot forms. After questions were raised on the side effects of its vaccine, the company had decided to recall its vaccine from all over the world.
What is the new threat of Covishield
VITT has emerged as a new disease due to the adenovirus vector based Oxford-AstraZeneca vaccine. Fatal blood autoantibodies to platelet factor 4 (PF 4) have been found to cause VITT. In separate research in 2023, scientists from Canada, North America, Germany and Italy found a new disease with PF4 antibodies, which was dangerous in some cases after naturally occurring adenovirus i.e. common cold infection.
What does the new research say?
In new research, Flinders University in Australia and other experts around the world found that the PF4 antibody in both VITT associated with adenovirus infection and classic adenoviral vector VITT has the same molecular structure. Flinders Professor Tom Gordon said that ‘the method of formation of dangerous antibodies in these disorders is similar. Our solutions are applicable to rare cases of blood clotting following VITT infection.
Molecular structure of PF4 antibody
In a research in 2022, the team of researchers had identified a genetic threat by detecting the molecular structure of PF4 antibody. In the new results published in the New England Journal of Medicine, important suggestions have been given regarding the safety of the vaccine. This research comes after AstraZeneca accepted it in a legal document presented in the British High Court in February.
It has been told that the company’s Covid vaccine can cause thrombotic thrombocytopenic syndrome (TTS) in very rare cases. In which blood clots can form and the number of platelets can decrease. Many deaths have also been claimed due to this in Britain.
Covaxin also has side effects
A research published in the science journal Springerlink states that Bharat Biotech’s Covaxin also has side effects. Respiratory infections, blood clotting and skin diseases were seen in about one-third of the people included in the study conducted at Banaras Hindu University (BHU). Researchers found that teenagers are at greater risk from Covaxin. Most of these are teenage girls and people suffering from allergies.
Shankha Shubhra Chakraborty, who conducted the study, said that the study was conducted on 1,024 people. In this, such people were selected, it has been 1 year since they got the vaccine. Of these, the number of teenagers was 635 and the number of adults was 291. Of these, problems related to respiratory infections like cold, cough were seen in 304 i.e. 47.9% teenagers and 124 i.e. 42.6% adults. At the same time, skin diseases were seen in teenagers and period problems were seen in 4.6% of the girls.
Disclaimer: Some of the information given in the news is based on media reports. Before implementing any suggestion, you must consult the concerned expert.
Also read: Health Tips: How many types of vitamins are needed to stay healthy? Know from experts
Check out below Health Tools-
Calculate Your Body Mass Index (BMI)
